Smart test could tailor breast cancer treatment and boost quality of life
Diagnosis
Recruiting now
This study is testing whether a special test called HER2DX can help doctors choose the best treatment for people with early-stage HER2-positive breast cancer. About 304 participants will be split into two groups: one group gets standard treatment without the test results, and the…
Phase: NA • Sponsor: Fundacio Clinic Barcelona • Aim: Diagnosis
Last updated Jun 16, 2026 12:53 UTC